Spots Global Cancer Trial Database for Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer
Official Title: Multicentric Phase II Study of Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-radiotherapy by Weekly Cisplatin - Docetaxel- Consolidation Chemotherapy by Docetaxel
Study ID: NCT00210171
Conditions
Study Description
Brief Summary: Feasibility of pragmatic concomitant chemo-radiotherapy association with 1 cycle of Induction chemotherapy, weekly chemo-radiotherapy, and consolidation chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre de radiothérapie d'Agen, Agen, , France
Clinique Tivoli, Bordeaux, , France
Polyclinique Bordeaux Nord, Bordeaux, , France
Centre Hospitalier Universitaire de Bordeaux, Bordeaux, , France
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest, Bordeaux, , France
Hôpital Robert Boulin, Libourne, , France
Clinique Francheville, Perigueux, , France
Contact Details
Name: François CHOMY, MD
Affiliation: Institut Bergonié
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
